[1]
E. Lajthia, “Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series”, Pharm Pract (Granada), vol. 17, no. 4, p. 1588, Dec. 2019.